Allen Charles W
Allen Charles W's purchase track record
Allen Charles W has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/18/2025 | BTCS | $261K | -49.3% | -45.0% | +11.1% |
| 3/16/2022 | BTCS | $27K | -55.3% | -59.0% | -9.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
SXTP to Release Babesiosis Interim Data and Appear on CNBC. 60 Degrees Pharmaceuticals will share interim results from its hospitalized babesiosis study and host a key‑opinion‑leader webinar later this month. The company will also discuss the data on the RedChip Small Stocks, Big Money show broadcast on CNBC and Bloomberg TV. A separate presentation of tafenoquine trial analysis is scheduled for Oct. 6. These events raise the profile of the company's clinical program.
Transaction History
| BTCS | ▼ Sell | Open Market | 168,000 | $204K | 6/15/2026 | View on chart |
| BTCS | ▼ Sell | Open Market | 87,000 | $100K | 6/12/2026 | View on chart |
| BTCS | ▼ Sell | Open Market | 165,000 | $183K | 6/11/2026 | View on chart |
| BTCS | ▼ Sell | Open Market | 150,000 | $179K | 6/10/2026 | View on chart |
| BTCS | ▼ Sell | Open Market | 105,000 | $133K | 6/9/2026 | View on chart |
| BTCS | ▲ Buy | Grant | 2,696,970 | — | 1/1/2026 | View on chart |
| BTCS | ▲ Buy | Grant | 199,432 | — | 1/1/2026 | View on chart |
| BTCS | ▼ Sell | Tax Withholding | 43,875 | — | 1/1/2026 | View on chart |
| BTCS | ▲ Buy | Open Market | 3,500 | $10K | 11/19/2025 | View on chart |
| BTCS | ▲ Buy | Open Market | 67,501 | $195K | 11/19/2025 | View on chart |
| BTCS | ▲ Buy | Open Market | 19,499 | $57K | 11/18/2025 | View on chart |
| BTCS | ▼ Sell | Open Market | 50,000 | $239K | 8/18/2025 | View on chart |
| BTCS | ▼ Sell | Open Market | 50,000 | $207K | 8/14/2025 | View on chart |
| BTCS | ▲ Buy | Option Exercise | 508,884 | $967K | 7/9/2025 | View on chart |
| BTCS | ▼ Sell | Gift | 8,000 | — | 7/2/2025 | View on chart |
| BTCS | ▼ Sell | Open Market | 65,000 | $94K | 4/9/2025 | View on chart |
| BTCS | ▼ Sell | Open Market | 50,000 | $72K | 4/8/2025 | View on chart |
| BTCS | ▼ Sell | Open Market | 85,000 | $117K | 4/7/2025 | View on chart |
| BTCS | ▼ Sell | Gift | 10,000 | — | 12/13/2024 | View on chart |
| BTCS | ▲ Buy | Grant | 124,402 | $134K | 9/13/2024 | View on chart |
| SXTP | ▲ Buy | Option Exercise | 4,000 | $892 | 5/16/2024 | View on chart |
| BTCS | ▼ Sell | Open Market | 50,000 | $78K | 2/20/2024 | View on chart |
| BTCS | ▼ Sell | Other | 50,000 | — | 1/12/2024 | View on chart |
| BTCS | ▲ Buy | Grant | 217,699 | — | 1/1/2024 | View on chart |
| BTCS | ▲ Buy | Grant | 50,000 | — | 1/1/2024 | View on chart |
| BTCS | ▼ Sell | Open Market | 100,000 | $120K | 4/10/2023 | View on chart |
| BTCS | ▲ Buy | Grant | 166,647 | — | 1/3/2023 | View on chart |
| BTCS | ▲ Buy | Open Market | 500 | $2K | 3/17/2022 | View on chart |
| BTCS | ▲ Buy | Open Market | 6,500 | $25K | 3/16/2022 | View on chart |
| BTCS | ▲ Buy | Grant | 173,611 | $0 | 1/2/2022 | View on chart |
| BTCS | ▲ Buy | Grant | 173,611 | $0 | 1/2/2022 | View on chart |
| BTCS | ▲ Buy | Grant | 173,611 | $0 | 1/2/2022 | View on chart |
| BTCS | ▲ Buy | Grant | 173,611 | $0 | 1/2/2022 | View on chart |
| BTCS | ▲ Buy | Grant | 173,611 | $0 | 1/2/2022 | View on chart |
| BTCS | ▼ Sell | Other | 2,954,118 | — | 9/14/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
BTCS Expands Imperium to Base, Targets $6M Gross Profit
BTCS Inc. announced plans to expand its Imperium platform to the Base network, aiming for $6 million in gross profit through DeFi growth. The company also confirmed it will present at the Water Tower Research Insights Conference on September 23, 2026. These moves highlight the firm's strategic focus on expanding its blockchain infrastructure and engaging with institutional investors.
BTCS Expands Imperium to Base, Targets $6M Gross Profit. BTCS Inc. announced plans to expand its Imperium platform to the Base network, aiming for $6 million in gross profit through DeFi growth. The company also confirmed it will present at the Water Tower Research Insights Conference on September 23, 2026. These moves highlight the firm's strategic focus on expanding its blockchain infrastructure and engaging with institutional investors.